WASHINGTON, April 13 -- Sen. Benjamin Cardin, D-Maryland, issued the following statement on April 12, 2023: * * * U.S. Senator Ben Cardin issued the following statement in response to a Texas federal district court ruling that would block access nationwide to mifepristone, a drug used in abortion medications. "If allowed to stand, last week's ruling out of Texas will have sweeping consequences on access to medication abortion. "The dangerous precedent overturning the decades-old approval of  more PR

WASHINGTON, April 13 -- Sen. Benjamin Cardin, D-Maryland, chairman of the Senate Small Business and Entrepreneurship Committee, issued the following statement on April 12, 2023: * * * U.S. Senator Ben Cardin (D-Md.), Chair of the Senate Committee on Small Business and Entrepreneurship, today responded to the Small Business Administration's finalized rules making changes to its lending programs. These rules lift the moratorium on licensing new Small Business Lending Companies, create a new SBLC more PR

WASHINGTON, April 13 -- Sen. Chris Van Hollen, D-Maryland, issued the following news release: U.S. Senators Chris Van Hollen and Ben Cardin (both D-Md.) joined Senate Majority Leader Chuck Schumer (D-N.Y.) and Senators Patty Murray (D-Wash.), Bernie Sanders (I-Vt.), Dick Durbin (D-Ill.), and Richard Blumenthal (D-Conn.) in submitting an amicus brief to the U.S. Court of Appeals for the Fifth Circuit in the case of Alliance for Hippocratic Medicine v. FDA, in support of the Biden administration' more PR